Table 6.
Spearman correlation analysis of pNF-H and clinical characteristics of the patients
| Parameter | R | p |
|---|---|---|
| 2hPG | 0.405** | < 0.001 |
| MNSI A | 0.380** | 0.001 |
| MNSI B | 0.433** | < 0.001 |
| TCNS | 0.495** | < 0.001 |
| HDL-c | − 0.267* | 0.021 |
| FPG | 0.229* | 0.047 |
| Posterior tibial nerve SNCV (distal) (m/s) | − 0.233* | 0.049 |
| Sural nerve SNAP (μV) | − 0.330* | 0.009 |
| ESC (feet) (μS) | − 0.314** | 0.006 |
| ESC (hands) (μS) | − 0.352** | 0.002 |
FPG fasting plasma glucose, 2hPG 2h postprandial plasma glucose, TG triglycerides, TC total cholesterol, HDL-c HDL cholesterol, ESC electrochemical skin conductance, SNCV sensory nerve conduction velocity, SNAP sensory nerve action potential, MNSI A,B Michigan Neuropathy Screening Instrument (parts A and B), TCNS Toronto Clinical Neuropathy Score
*p < 0.05
**p < 0.01